The Expert Angle

Medlior is a well-known and trusted industry leader.

Our team is dedicated to delivering high-quality research that provides a solid basis for informed decision-making.

Medlior’s Expert Angle offers the inside track on new studies, industry hot topics, and what you need to know in the fast-paced world of clinical research, all from the point of view of the Medlior team of experts. From the latest topics and trends to the foundations of health and medical research, Medlior explores topics relevant to clients and the world.

Using Integrated Real-World Data in Alberta to Develop Personalized Follow-up Care Pathways for Cancer Survivors

Using Integrated Real-World Data in Alberta to Develop Personalized Follow-up Care Pathways for Cancer Survivors

This study will provide an integrated data source to inform follow-up clinical care pathways for cancer survivors in Alberta The odds of long-term recovery from cancer have never been better. In the 1940s only 25% of Canadians survived a cancer diagnosis, compared with 60% ...
Real World Data and Inflammatory Bowel Disease

Real World Data and Inflammatory Bowel Disease

Real World Data could be used to create a better understanding of the burden of diseases such as inflammatory bowel disease and improve health outcomes
Real World Data can impact economic analyses of Huntington’s Disease

Real World Data can impact economic analyses of Huntington’s Disease

Studies on the costs of Huntington’s Disease are lacking in Canada. A real-world evidence study will be vital to future economic analyses.
Estimating the burden of illness of obesity in Alberta

Estimating the burden of illness of obesity in Alberta

Obesity has traditionally been considered a result of lifestyle factors, including poor diet and physical inactivity, and thus, it has been considered a preventable condition. However, the Canadian Medical Association has recently declared obesity to be a chronic medical disease due to the associated negative health effects.9 While lifestyle modifications can prevent obesity in some, further pharmaceutical intervention is required to mitigate the growing obesity epidemic in Canada and reduce the national burden of disease.
Insights into how Real World Radar can improve research

Insights into how Real World Radar can improve research

Real World Radar by Medlior, houses real world databases from across the world. Real world data provides chances for real world evidence to improve care
Applications of Natural Language Processing and Machine Learning to Develop Oncology Decision Aid for Multiple Myeloma in Alberta using Administrative Health Data

Applications of Natural Language Processing and Machine Learning to Develop Oncology Decision Aid for Multiple Myeloma in Alberta using Administrative Health Data

In Canada, approximately 1,700 men and 1,200 women were diagnosed with multiple myeloma (MM) in 2017. While this only corresponds to 1.6% and 1.2% of new cancer cases each year, the approximate five-year net survival rate according to the Canadian Cancer Society (estimated for the years ...
Review and analysis of first-line treatment of advanced epidermal growth factor receptor mutation positive non-small cell lung cancer.

Review and analysis of first-line treatment of advanced epidermal growth factor receptor mutation positive non-small cell lung cancer.

Medlior continues to have our work featured in respected publications and this month we’re pleased to be published in Future Oncology. Our manuscript looks at First-line treatment of advanced epidermal growth factor receptor mutation positive non-small cell lung cancer: A systematic review and network meta-analysis. Read more here.
Medlior – Continuing Our Growth For The Future

Medlior – Continuing Our Growth For The Future

Since 2008, when Founder Tara Cowling started Medlior Health Outcomes Research, we have grown by leaps and bounds. The Medlior team now has 15 full-time staff with another 40 regular contractors - all of whom hold advanced degrees - that allow us to offer a range of research services ...
HTAi 2019: Best Practices for Leveraging Artificial Intelligence in the Systematic Review Process

HTAi 2019: Best Practices for Leveraging Artificial Intelligence in the Systematic Review Process

During the 2019 annual HTAi meeting in Cologne, Germany, Medlior’s Kelly Larkin-Kaiser along with Peter O’Blenis and Jennifer Tetzlaff from Evidence Partners hosted a workshop titled: “Best Practices for Leveraging Artificial Intelligence in the Systematic Review Process” The workshop focused ...
Medlior awarded inaugural Women’s Entrepreneurship Fund from Government of Canada

Medlior awarded inaugural Women’s Entrepreneurship Fund from Government of Canada

Fund awarded to Canadian women entrepreneurs to provide market opportunities and support growth Calgary, Alberta (May 20, 2019) - Calgary based company, Medlior Health Outcomes Research Ltd., has been awarded the Women Entrepreneurship Fund by the Government of Canada. This unique fund ...
Gene Therapy and the Treatment of Haemophilia

Gene Therapy and the Treatment of Haemophilia

Gene therapy is a growing area of interest for the treatment of several diseases. These therapies are intended to offer a one-time treatment to modify a person’s genes through a variety of mechanisms in order to treat or cure a disease.  These mechanisms include: i) replacing the gene with a ...
Cholesterol-lowering drugs are under-prescribed for prevention of atherosclerotic cardiovascular disease

Cholesterol-lowering drugs are under-prescribed for prevention of atherosclerotic cardiovascular disease

  Cholesterol-lowering drugs are under-prescribed for prevention of atherosclerotic cardiovascular disease In a large retrospective study, investigators identify a significant treatment gap in managing patients with and at risk for clinical atherosclerotic cardiovascular disease, reports ...